
|Articles|February 1, 2006
Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice
Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
Top 5 pediatric health headlines you missed in May 2026
3
Supporting children with hidradenitis suppurativa beyond medical treatment, with Colleen Cotton, MD
4
FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults
5





